One hundred reasons to celebrate women in ophthalmology
Charles Holmes and Ignacio Tuduri on the Allergan AbbVie vision for the future – post-merger
How can data-driven in vivo reprogramming be used to treat retinal and optic nerve degeneration?
E. Randy Craven,
I. Paul Singh
Three glaucoma specialists assess the potential of the FDA-approved bimatoprost implant
My memories of Alan S. Crandall – physician and friend
We remember a giant of ophthalmology, Alan S. Crandall
Celebrating the legacy of Alan S. Crandall
The pandemic has forced physicians to rethink glaucoma treatment – starting with updated tools and protocols for safety-conscious encounters
MIGS has revolutionized glaucoma surgery, but there’s still room for improvement. Let’s talk XEN…
Alice T. Epitropoulos
Are sustained-release drugs the answer to ophthalmology’s topical drop problem?
by Santen Pharmaceuticals
Is PRESERFLO™ MicroShunt a viable and predictable alternative to trabeculectomy?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.